These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 21791012)

  • 1. Synthesis and anti-hypercholesterolemic evaluations of calcium salts of 4-substituted quinoline-based mevalonic acid.
    Hao Q; Cai Z; Pan J; Li Y; Xia Y; Min Y; Sheng Y; Zhou W
    Chem Biol Drug Des; 2011 Oct; 78(4):730-3. PubMed ID: 21791012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery, synthesis and evaluation of novel cholesterol absorption inhibitors.
    Zhu X; Ji J; Huang D; Zhu Y; Tang C; Yang X; Qian H; Huang W
    Chem Biol Drug Des; 2012 Sep; 80(3):426-33. PubMed ID: 22642541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and HMG-CoA reductase inhibition of 2-cyclopropyl-4-thiophenyl-quinoline mevalonolactones.
    Zhao S; Zhou W; Liu J
    Bioorg Med Chem; 2009 Dec; 17(23):7915-23. PubMed ID: 19879766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin increases blood ratios of vitamin E/low-density lipoprotein cholesterol and coenzyme Q10/low-density lipoprotein cholesterol in hypercholesterolemic patients.
    Liu CS; Lii CK; Chang LL; Kuo CL; Cheng WL; Su SL; Tsai CW; Chen HW
    Nutr Res; 2010 Feb; 30(2):118-24. PubMed ID: 20226997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypolipidemic effect of fresh Triticum aestivum (wheat) grass juice in hypercholesterolemic rats.
    Kothari S; Jain AK; Mehta SC; Tonpay SD
    Acta Pol Pharm; 2011; 68(2):291-4. PubMed ID: 21485304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and HMG CoA reductase inhibition of 4-thiophenyl quinolines as potential hypocholesterolemic agents.
    Cai Z; Zhou W; Sun L
    Bioorg Med Chem; 2007 Dec; 15(24):7809-29. PubMed ID: 17851082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct effects of pitavastatin and atorvastatin on lipoprotein subclasses in patients with Type 2 diabetes mellitus.
    Shimabukuro M; Higa M; Tanaka H; Shimabukuro T; Yamakawa K; Masuzaki H
    Diabet Med; 2011 Jul; 28(7):856-64. PubMed ID: 21244474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitavastatin: efficacy and safety in intensive lipid lowering.
    Hayashi T; Yokote K; Saito Y; Iguchi A
    Expert Opin Pharmacother; 2007 Oct; 8(14):2315-27. PubMed ID: 17927486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of soy protein on lipoprotein lipids and fecal bile acid excretion in men and women with moderate hypercholesterolemia.
    Maki KC; Butteiger DN; Rains TM; Lawless A; Reeves MS; Schasteen C; Krul ES
    J Clin Lipidol; 2010; 4(6):531-42. PubMed ID: 21122701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.
    Conard SE; Bays HE; Leiter LA; Bird SR; Rubino J; Lowe RS; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2008 Dec; 102(11):1489-94. PubMed ID: 19026302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study).
    Foody JM; Brown WV; Zieve F; Adewale AJ; Flaim D; Lowe RS; Jones-Burton C; Tershakovec AM
    Am J Cardiol; 2010 Nov; 106(9):1255-63. PubMed ID: 21029821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical evaluation of the hypocholesterolemic effects of an inhibitor of cholesterol synthesis: mevalonic acid].
    Del Nero E; Aloe N; Augeri C; Avola F; Carta G; Cavagnaro A; De Grandi R; Gianfreda M; Magro GP; Mazzarello GP
    Clin Ter; 1992 Jul; 141(7):47-50. PubMed ID: 1505176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypocholesterolemic and antioxidant effects of aqueous extracts from the dried calyx of Hibiscus sabdariffa L. in hypercholesterolemic rats.
    Hirunpanich V; Utaipat A; Morales NP; Bunyapraphatsara N; Sato H; Herunsale A; Suthisisang C
    J Ethnopharmacol; 2006 Jan; 103(2):252-60. PubMed ID: 16213683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HMG-CoA-reductase inhibitors: a new principle in the treatment of hypercholesterolemia].
    Saxenhofer H; Weidmann P
    Ther Umsch; 1990 Jun; 47(6):509-13. PubMed ID: 2375007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects.
    Gylling H; Miettinen TA
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):19-23. PubMed ID: 12125225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease.
    Leiter LA; Bays H; Conard S; Bird S; Rubino J; Hanson ME; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2008 Dec; 102(11):1495-501. PubMed ID: 19026303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
    Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course differences for statin-induced pleiotropic effects in hypercholesterolemic patients.
    Sakabe K; Fukuda N; Wakayama K; Nada T; Shinohara H; Tamura Y
    Int J Cardiol; 2004 Mar; 94(1):111-7. PubMed ID: 14996484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.